An assessment of psychiatric disturbances in graves disease in a medical college in eastern India

Nigerian Journal of Clinical Practice

Volumn 15, Issue 3, 2012, Pages 276-279

  Chattopadhyay, C ^a   Chakrabarti, N ^a   Ghosh, S ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Graves' disease; Psychiatric illness; Treatment outcome

Indexed keywords

ANTITHYROID AGENT; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; FEMALE; GRAVES DISEASE; HUMAN; INDIA; MALE; MEDICAL SCHOOL; MIDDLE AGED; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; INDIA; MALE; MIDDLE AGED; SCHOOLS, MEDICAL; YOUNG ADULT;

EID: 84866380009     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.100620     Document Type: Article

References (16)

1. Sonino N, Girelli ME, Boscaro M, Fallo F, Busnardo B, Fava GA. Life events in the pathogenesis of Graves' disease. A controlled study. ActaEndocrinol (Copenh) 1993;128:293-6. (Pubitemid 23127996)
2. Hamilton M, The assessment of anxiety states by rating. Br J Med Psychol 1959;32:50-5.
3. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:380-9.
4. Goodman WK, Price LH, Rusmussen SA, Mazure C, Fleischmann RL, Hill CL, et al. The Yale-Brown obscessive compulsive scale 1-Devolpement use reliability. Arch Gen Psychiatry 1989;46:106-11
5. Brownlie BE, Rae AM, Walshe JW, Wells JE. Psychoses associated with thyrotoxicosis-'thyrotoxic psychosis'. A report of 18 cases, with statistical analysis of incidence. Eur J Endocrinol 2000;142:438-44. (Pubitemid 30341173)
6. Kathol RG, Turner R, Delahunt J. Depression and anxiety associated with hyperthyroidism: Response to antithyroid therapy. Psychosomatics 1986;27:501-5. (Pubitemid 16002719)
7. Lu CL, Lee YC, Tsai SJ, Hu PG, Sim CB. Psychiatric disturbances associated with hyperthyroidism: An analysis report of 30 cases. Zhonghua Yi Xue Za Zhi (Taipei) 1995;56:393-8.
8. nd ed. Philadelphia: Lippincott-Raven; 1996. p. 337-45.
9. Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hørding M, Perrild H, Waldemar G. Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 2004;151:549-55. (Pubitemid 39562508)
10. Lee IT, Sheu WH, Liau YJ, Lin SY, Lee WJ, Lin CC. Relationship of stressful life events, anxiety and depression to hyperthyroidism in an Asian population. Horm Res 2003;60:247-51. (Pubitemid 37465087)
11. Farid M, Roch-Levecq AC, Levi L, Brody BL, Granet DB, Kikkawa DO. Psychological disturbance in graves ophthalmopathy. Arch Ophthalmol 2005;123:491-6. (Pubitemid 40489920)
12. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM, Quality of life in patients with Graves opthalmopathy is markedly decreased: Measurement by the medical outcomes study instrument. Thyroid 1997;7:885-9. (Pubitemid 28041663)
13. Terwee C, Wakelkamp I, Tan S, Dekker F, Prummel MF, Wiersinga W. Long - term effects of Graves' opthalmopathy on health related quality of life. Eur J Endocrinol 2002;146:751-7.
14. Rockey PH, Griep RJ. Behavioral dysfunction in hyperthyroidism. Improvement with treatment. Arch Intern Med 1980;140:1194-7. (Pubitemid 10048815)
15. Fahrenfort JJ, Wilterdink AM, Van der Veen EA. Long-term residual complaints and psychosocial sequelae after remission of hyperthyroidism. Psychoneuroendocrinology 2000;25:201-11. (Pubitemid 29525392)
16. Thomsen AF, Kvist TK, Andersen PK, Kessing LV. Increased risk of affective disorder following hospitalisation with hyperthyroidism - a register-based study. Eur J Endocrinol 2005;152:535-43. (Pubitemid 40575798)